Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Portenoy

Showing results (261-270 of 354) with videos related to

Pageof 36
Sort By:
Journal of Neuro-Oncology|December 1, 1990
Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemiasJ G Kaplan, T G DeSouza, A Farkash, et al.
Journal of Pain and Symptom Management|August 29, 2017
Symptom Distress Among Diverse Patients Referred for Community-Based Palliative Care: Sociodemographic and Medical CorrelatesLara Dhingra, Malcolm Barrett, Helena Knotkova, et al.
Pain|December 1, 1986
Compulsive thalamic self-stimulation: a case with metabolic, electrophysiologic and behavioral correlatesRussell K Portenoy, Jens O Jarden, John J Sidtis, et al.
Anesthesiology|January 1, 1993
Transdermal fentanyl for cancer pain. Repeated dose pharmacokineticsR K Portenoy, M A Southam, S K Gupta, et al.
Oncology (Williston Park, N.Y.)|June 5, 1999
A 38-year-old man with pancreatic cancerR K Portenoy, S Du Pen, F M Ferrante, et al.
The Oncologist|March 16, 2011
Pain in underserved community-dwelling Chinese American cancer patients: demographic and medical correlatesLara Dhingra, Kin Lam, Peter Homel, et al.
Pain|October 1, 1991
Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failureRussell K Portenoy, Kathleen M Foley, James Stulman, et al.
Clinical Pharmacology and Therapeutics|July 1, 1992
Treatment of opioid-induced constipation with oral naloxone: a pilot studyJ A Culpepper-Morgan, C E Inturrisi, R K Portenoy, et al.
Journal of Pain and Symptom Management|May 15, 2002
Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant painMark Palangio, Donald W Northfelt, Russell K Portenoy, et al.
Stroke|November 1, 1984
Headache in cerebrovascular diseaseR K Portenoy, C J Abissi, R B Lipton, et al.
Pageof 36

Showing results (261-270 of 354) with videos related to

Sort By:
Pageof 36
Journal of Neuro-Oncology|December 1, 1990
Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemiasJ G Kaplan, T G DeSouza, A Farkash, et al.
Journal of Pain and Symptom Management|August 29, 2017
Symptom Distress Among Diverse Patients Referred for Community-Based Palliative Care: Sociodemographic and Medical CorrelatesLara Dhingra, Malcolm Barrett, Helena Knotkova, et al.
Pain|December 1, 1986
Compulsive thalamic self-stimulation: a case with metabolic, electrophysiologic and behavioral correlatesRussell K Portenoy, Jens O Jarden, John J Sidtis, et al.
Anesthesiology|January 1, 1993
Transdermal fentanyl for cancer pain. Repeated dose pharmacokineticsR K Portenoy, M A Southam, S K Gupta, et al.
Oncology (Williston Park, N.Y.)|June 5, 1999
A 38-year-old man with pancreatic cancerR K Portenoy, S Du Pen, F M Ferrante, et al.
The Oncologist|March 16, 2011
Pain in underserved community-dwelling Chinese American cancer patients: demographic and medical correlatesLara Dhingra, Kin Lam, Peter Homel, et al.
Pain|October 1, 1991
Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failureRussell K Portenoy, Kathleen M Foley, James Stulman, et al.
Clinical Pharmacology and Therapeutics|July 1, 1992
Treatment of opioid-induced constipation with oral naloxone: a pilot studyJ A Culpepper-Morgan, C E Inturrisi, R K Portenoy, et al.
Journal of Pain and Symptom Management|May 15, 2002
Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant painMark Palangio, Donald W Northfelt, Russell K Portenoy, et al.
Stroke|November 1, 1984
Headache in cerebrovascular diseaseR K Portenoy, C J Abissi, R B Lipton, et al.
Pageof 36